Rh antigens reside in Rh polypeptides of the red cell membrane and form one of the most complex polymorphisms in humans. They are clinically important, accounting for the most common incompatibility found in blood transfusion and hemolytic disease of the newborn. They appear to be essential membrane components because red cells devoid of all Rh antigens (Rh/null phenotype) manifest stomatocytosis, shortened in vivo survival, and multiple membrane abnormalities. Our objectives are to unravel the structure/function relationships of the Rh system and delineate the genetic mechanisms for its phenotypic diversity.
The specific aims are: 1) To clone and map the entire RH locus and establish the physical order and transcriptional direction of its gene members. 2) To determine the molecular basis of different Rh antigens and phenotypes with emphasis on how DNA recombination and other genetic mechanisms modulate gene structure and cause antigenic variation. 3) To study the expression of a novel Rh transcript that may characterize the d (D-negative) haplotypes and determine the mechanism that results in its activation. 4) To study differential splicing of the Rh genes and determine its role in the onset and regulation of Rh gene expression during erythroid development. 5) To identify the Rh/null and Rhmod genes and determine whether the primary defect is in the Rh genes themselves or in the Rh-related candidate genes. The proposed studies promise to provide insights into structure/function relationships of Rh proteins and the genetic mechanisms leading to one of the most polymorphic human systems. The knowledge gained will deepen our understanding of clinical problems associated with blood transfusion and hemolytic reactions and provide a basis for the clinical service to use molecular approaches in transfusion medicine.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL054459-02
Application #
6242452
Study Section
Project Start
1997-01-01
Project End
1997-12-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
New York Blood Center
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10065
Migliaccio, Anna Rita (2018) A vicious interplay between genetic and environmental insults in the etiology of blood cancers. Exp Hematol 59:9-13
Ciaffoni, Fiorella; Cassella, Elena; Varricchio, Lilian et al. (2015) Activation of non-canonical TGF-?1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis. Blood Cells Mol Dis 54:234-41
Hricik, Todd; Federici, Giulia; Zeuner, Ann et al. (2013) Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera. Am J Hematol 88:723-9
Poletto, Valentina; Rosti, Vittorio; Villani, Laura et al. (2012) A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation. Blood 120:3112-7
Huang, Cheng-Han; Ye, Mao (2010) The Rh protein family: gene evolution, membrane biology, and disease association. Cell Mol Life Sci 67:1203-18
Zhu, Xiang; Rivera, Alicia; Golub, Mari S et al. (2009) Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel). Am J Hematol 84:492-8
Mutschler, Manuel; Magin, Angela S; Buerge, Martina et al. (2009) NF-E2 overexpression delays erythroid maturation and increases erythrocyte production. Br J Haematol 146:203-17
Lee, Soohee; Sha, Quan; Wu, Xu et al. (2007) Expression profiles of mouse Kell, XK, and XPLAC mRNA. J Histochem Cytochem 55:365-74
Walker, Ruth H; Jung, Hans H; Tison, Francois et al. (2007) Phenotypic variation among brothers with the McLeod neuroacanthocytosis syndrome. Mov Disord 22:244-8
Walker, Ruth H; Danek, Adrian; Uttner, Ingo et al. (2007) McLeod phenotype without the McLeod syndrome. Transfusion 47:299-305

Showing the most recent 10 out of 143 publications